Should the second generation antipsychotic agents be used as drugs of choice?
Rimón, R.; Leinonen, E.
Duodecim; Laaketieteellinen Aikakauskirja 118(6): 585-590
2002
ISSN/ISBN: 0012-7183 PMID: 12233002 Document Number: 547806
Document emailed within 1 workday
Related Documents
Diurni, M.; Baranzini, F.; Costantini, C.; Poloni, N.; Vender, S.; Callegari, C. 2009: Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study Recenti Progressi in Medicina 100(2): 103Lehtonen, J.; Tacke, U. 2003: Difficult choice between various antipsychotic agents--should we broaden our view? Duodecim; Laaketieteellinen Aikakauskirja 119(12): 1159-1162
Firestone, A. 2005: Weight gain and diabetes with "second-generation" antipsychotic drugs Medical Journal of Australia 182(12): 652-653
Sami, T.; Kabadi, U.M.; Moshiri, S. 1996: The effect on metabolic control of second-generation sulfonylurea drugs in patients with NIDDM after secondary failure to first-generation agents Journal of Family Practice 43(4): 370-374
Nightengale, B.S.; Crumly, J.M.; Liao, J.; Lawrence, B.J.; Jacobs, E.W. 1998: Economic outcomes of antipsychotic agents in a Medicaid population: traditional agents vs. risperidone Psychopharmacology Bulletin 34(3): 373-382
Gosselin, O.; Di Scala, G.; Ribeyre, J.M.; Kahn, J.P. 1996: New antipsychotic agents: new paths of research on the notion of atypical agents L'Encephale 22(Special Issue 6): 3-6
2003: Choice of an antipsychotic Medical Letter on Drugs and Therapeutics 45(1172): 102-104
Huddle, K.; Milne, F.J. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors are the drugs of choice in diabetic nephropathy South African Medical Journal 80(5): Suppl 10
Dresse, A. 1996: Neuroleptics or antipsychotic agents Revue Medicale de Liege 51(1): 65-69
Soen, S. 2007: First choice drug for treatment of osteoporosis and the strategic points for choice of drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 325-328
Casey, D.E. 1996: Side effect profiles of new antipsychotic agents Journal of Clinical Psychiatry 57(Suppl): 40-45; Discussion 46-52
Vanden Bussche, G.; Gelders, Y.G.; Heylen, S.L. 1990: Development of new antipsychotic drugs Acta Psiquiatrica y Psicologica de America Latina 36(1-2): 13-25
Vieta, E. 2004: Antipsychotic drugs and pregnancy Medicina clinica 123(13): 517-8; author reply 518
Raskind, M.A.; Risse, S.C. 1986: Antipsychotic drugs and the elderly Journal of Clinical Psychiatry 47 Suppl: 17-22
Bourin, M. 2006: Pharmacology of antipsychotic drugs L'Encephale 32 Pt 2: S8-S9
Wengert, J.W.; Ahmed, I. 1979: Antipsychotic drugs: problems and guidelines Nebraska Medical Journal 64(5): 139-140
Omori, T. 2001: Efficacy of atypical antipsychotic agents for maintenance therapy of schizophrenia Seishin Shinkeigaku Zasshi 103(6): 470-475
Lee, B.S. 1986: Possibility of hyperpyrexia with antipsychotic and anticholinergic drugs Journal of Clinical Psychiatry 47(11): 571
Deuschle, M. 2005: Diabetes in treatment with antipsychotic drugs: who is at risk] MMW Fortschritte der Medizin 147(51-52): 34
Dumortier, G.; Cabaret, W.; Stamatiadis, L.; Saba, G.; Benadhira, R.; Rocamora, J.-F.; Aubriot-Delmas, B.; Glikman, J.; Januel, D. 2002: Hepatic tolerance of atypical antipsychotic drugs L'Encephale 28(6 Part 1): 542-551